Barinthus Biotherapeutics
 | |
| Industry | Vaccines Immunotherapy Biotechnology |
|---|---|
| Founded | 2016 |
| Founder | |
| Headquarters | , |
| Website | vaccitech |
Vaccitech Limited is a biotechnology company developing seasonal Influenza vaccines[1][2][3] and immunotherapies for prostate cancer.[4][5] The company's platform includes Chimpanzee Adenovirus Oxford (ChAdOx) and Modified Vaccinia Ankara (MVA), two viral vectors which mimic viral disease in human cells and elicit T cell responses to pathogens and tumours.[6] The company was founded in 2016 as a University spin-off by Sarah Gilbert and Adrian V. S. Hill at the Jenner Institute, University of Oxford.[7][8][9][10]
Vaccitech has been financed and supported by Google Ventures (GV), Sequoia Capital, GeneMatrix, Liontrust Asset Management, Korea Investment Partners and Oxford Sciences Innovation (OSI).[11] As of 2020[update] investment in vaccitech has included over £20m of series A round funding.[10]
References
- ^ Eisenstein, Michael (2019). "Towards a universal flu vaccine". Nature. 573 (7774): S50–S52. doi:10.1038/d41586-019-02751-w. ISSN 0028-0836. PMID 31534251.
- ^ Wei, Chih-Jen; Crank, Michelle C.; Shiver, John; Graham, Barney S.; Mascola, John R.; Nabel, Gary J. (2020). "Next-generation influenza vaccines: opportunities and challenges". Nature Reviews Drug Discovery. 19 (4): 239–252. doi:10.1038/s41573-019-0056-x. ISSN 1474-1776. PMC 7223957. PMID 32060419.
- ^ Anon (2018). "A checkup for the flu vaccine". Nature Medicine. 24 (4): 375–375. doi:10.1038/nm.4535. ISSN 1078-8956. PMID 29634696.
- ^ Barinthus Biotherapeutics on X
- ^ Anon (2016). "Vaccitech Limited". companieshouse.gov.uk. London: Companies House.
- ^ Anon (2019). "Vaccitech - Creating ways to treat and prevent disease". vaccitech.co.uk. Vaccitech Limited.
- ^ Anon (2020). "Company listing". crunchbase.com. Crunchbase. Retrieved 2020-04-24.
- ^ Anon (2019). "Vaccitech Ltd". bloomberg.com. Bloomberg News.
- ^ Anon (2016). "Universal flu vaccine under development by Oxford spinout Vaccitech". ox.ac.uk. University of Oxford.
- ^ a b Anon (2019). "Vaccitech secures £20m Series A with GV, OSI and Sequoia China". innovation.ox.ac.uk. Oxford University Innovation.
- ^ Anon (2019). "About Vaccitech". vaccitech.co.uk. Vaccitech Limited.
